{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T09:51:06Z","timestamp":1770025866112,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc. Diabetol. \u2013 Endocrinol. Rep."],"DOI":"10.1186\/s40842-025-00266-0","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T23:02:24Z","timestamp":1769986944000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and association of metabolic syndrome components with benign prostate hyperplasia"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4846-3210","authenticated-orcid":false,"given":"Hundesa Emana","family":"Urgesa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tesfaye Adugna","family":"Leta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teka Obsa","family":"Feyisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanuel Hika","family":"Bati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kassa Tefera","family":"Tulu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bedasa Addisu","family":"Nasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zerihun Aseffa","family":"Tereffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"266_CR1","unstructured":"Omesh Singh; Srinivasa Rao Bolla. Anatomy, Abdomen and Pelvis, Prostate - StatPearls - NCBI Bookshelf (nih.gov) The. 2023."},{"key":"266_CR2","unstructured":"Mona Sharma S, Gupta. Bodhana Dhole and AK. Basics of human andrology. Basics Hum Androl. 2017;(26 August 2020)."},{"key":"266_CR3","unstructured":"Baradhi MNSWLKM. Benign prostatic hyperplasia [Internet]. 2024. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK558920\/."},{"issue":"5","key":"266_CR4","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/bju.14007","volume":"121","author":"GI Russo","year":"2018","unstructured":"Russo GI, Regis F, Spatafora P, Frizzi J, Urz\u00ec D, Cimino S, et al. Association between metabolic syndrome and intravesical prostatic protrusion in patients with benign prostatic enlargement and lower urinary tract symptoms (MIPS Study). BJU Int. 2018;121(5):799\u2013804.","journal-title":"BJU Int"},{"key":"266_CR5","unstructured":"Minter CGSWLDA. Available link:https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459218\/. 2023;2023."},{"issue":"5","key":"266_CR6","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1159\/000496289","volume":"65","author":"S Madersbacher","year":"2019","unstructured":"Madersbacher S, Sampson N, Culig Z. Pathophysiology of benign prostatic hyperplasia and benign prostatic enlargement: A Mini-Review. Gerontology. 2019;65(5):458\u201364.","journal-title":"Gerontology"},{"issue":"2","key":"266_CR7","doi-asserted-by":"publisher","first-page":"170","DOI":"10.4103\/0970-1591.126900","volume":"30","author":"ND Patel","year":"2014","unstructured":"Patel ND, Parsons JK. Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction. Indian J Urol. 2014;30(2):170\u20136.","journal-title":"Indian J Urol"},{"key":"266_CR8","doi-asserted-by":"publisher","unstructured":"Mubenga LE, Gruson D, Hermans MP, Bwenge E, Tombal B. Diabetes & Metabolic Syndrome: Clinical Research & Reviews Metabolic syndrome components and prostatic hyperplasia among diabetic and non-diabetic men in the Eastern DR Congo : a cross-sectional study. Diabetes Metab Syndr Clin Res Rev [Internet]. 2019;13(1):776\u201380. Available from: https:\/\/doi.org\/10.1016\/j.dsx.2018.11.064.","DOI":"10.1016\/j.dsx.2018.11.064"},{"issue":"3","key":"266_CR9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ajur.2017.05.001","volume":"4","author":"H-Y Ngai","year":"2017","unstructured":"Ngai H-Y, Yuen K-KS, Ng C-M, Cheng C-H, Chu S-KP. Metabolic syndrome and benign prostatic hyperplasia: an update. Asian J Urol. 2017;4(3):164\u201373.","journal-title":"Asian J Urol"},{"key":"266_CR10","doi-asserted-by":"publisher","unstructured":"Parikesit D, Mochtar CA, Umbas R, Rizal A, Hariandy A. The impact of obesity towards prostate diseases. Prostate Int [Internet]. 2016;4(1):1\u20136. Available from: https:\/\/doi.org\/10.1016\/j.prnil.2015.08.001.","DOI":"10.1016\/j.prnil.2015.08.001"},{"issue":"1","key":"266_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/pcan.2015.43","volume":"19","author":"Q He","year":"2016","unstructured":"He Q, Wang Z, Liu G, Daneshgari F, MacLennan GT, Gupta S. Metabolic syndrome, inflammation and lower urinary tract symptoms: possible translational links. Prostate Cancer Prostatic Dis. 2016;19(1):7\u201313.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"266_CR12","unstructured":"Szekeres M. Role of the Endocannabinoid System in Metabolic Control Processes and in the Pathogenesis of Metabolic Syndrome: an Update. 2023."},{"key":"266_CR13","unstructured":"Available at: Jimma University Medical Center Accesed date: 10\/29\/2024 Jimma University Medical Center. 2024;5058."},{"issue":"1","key":"266_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12894-023-01365-9","volume":"23","author":"M Daher","year":"2023","unstructured":"Daher M, Saqer T, Jabr M, Al-Mousa S. Benign prostatic hyperplasia and metabolic syndrome; prevalence and association: a cross-sectional study in Syria. BMC Urol. 2023;23(1):1\u20136.","journal-title":"BMC Urol"},{"issue":"17","key":"266_CR15","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American heart Association\/National heart, Lung, and blood Institute scientific statement. Circulation. 2005;112(17):2735\u201352.","journal-title":"Circulation"},{"issue":"2","key":"266_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00345-015-1626-0","volume":"34","author":"C Zou","year":"2016","unstructured":"Zou C, Gong D, Fang N, Fan Y. Meta-analysis of metabolic syndrome and benign prostatic hyperplasia in Chinese patients. World J Urol. 2016;34(2):281\u20139.","journal-title":"World J Urol"},{"key":"266_CR17","unstructured":"Afroz T, Sultana N, Rahman MH, Begum A, Muna FZ, Rahman MM. Association Between Metabolic Syndrome and Benign Prostate Hyperplasia. 2015."},{"issue":"1","key":"266_CR18","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/bju.12931","volume":"116","author":"P Pashootan","year":"2015","unstructured":"Pashootan P, Ploussard G, Cocaul A, De Gouvello A, Desgrandchamps F. Association between metabolic syndrome and severity of lower urinary tract symptoms (LUTS): an observational study in a 4666 European men cohort. BJU Int. 2015;116(1):124\u201330.","journal-title":"BJU Int"},{"key":"266_CR19","first-page":"757","volume":"i","author":"JH Jeong","year":"2011","unstructured":"Jeong JH, Kim ET, Kim DK. Association of metabolic syndrome and benign prostate enlargement. Young Korean Males. 2011;i:757\u201362.","journal-title":"Young Korean Males"},{"key":"266_CR20","doi-asserted-by":"crossref","unstructured":"Park JS, Koo KC, Kim HK, Chung BH, Lee KS. Impact of metabolic syndrome-related factors on the development of benign prostatic hyperplasia and lower urinary tract symptoms in Asian population. 2019;42(July).","DOI":"10.1097\/MD.0000000000017635"},{"key":"266_CR21","doi-asserted-by":"publisher","unstructured":"Mubenga LE, Hermans MP, Chimanuka D, Muhindo L, Bwenge E, Tombal B. Prostate volume and its relationship with anthropometric variables among different ethnic groups of South-Kivu, DR Congo. African J Urol [Internet]. 2020;26(1). Available from: https:\/\/doi.org\/10.1186\/s12301-020-00040-x.","DOI":"10.1186\/s12301-020-00040-x"},{"issue":"12","key":"266_CR22","doi-asserted-by":"publisher","first-page":"763","DOI":"10.36347\/sasjs.2022.v08i12.006","volume":"8","author":"EA Udoh","year":"2022","unstructured":"Udoh EA, Usoro AJ, Essiet IU. Association between diabetes mellitus and benign prostatic hyperplasia. SAS J Surg. 2022;8(12):763\u20137.","journal-title":"SAS J Surg"},{"issue":"1","key":"266_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.52142\/omujecm.40.1.19","volume":"40","author":"IBGTY Yatindra","year":"2023","unstructured":"Yatindra IBGTY, Prabandari AASM, Tirtayasa PMW, Yatindra IBT, Diatmika AANO, Mernika KC. Correlation of blood glucose and prostatic-related parameters in patients with prostate enlargement. J Exp Clin Med. 2023;40(1):90\u20133.","journal-title":"J Exp Clin Med"},{"key":"266_CR24","doi-asserted-by":"publisher","unstructured":"Agrawal A. Metabolic syndrome and BPH: What do we know? Med J Armed Forces India [Internet]. 2017;73(1):102\u20133. Available from: https:\/\/doi.org\/10.1016\/j.mjafi.2016.11.011.","DOI":"10.1016\/j.mjafi.2016.11.011"},{"issue":"2","key":"266_CR25","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/pros.10096","volume":"52","author":"AP Chokkalingam","year":"2002","unstructured":"Chokkalingam AP, Gao Y-T, Deng J, Stanczyk FZ, Sesterhenn IA, Mostofi FK, et al. Insulin-like growth factors and risk of benign prostatic hyperplasia. Prostate. 2002;52(2):98\u2013105.","journal-title":"Prostate"},{"issue":"4","key":"266_CR26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.5213\/inj.1632584.292","volume":"20","author":"JH Jung","year":"2016","unstructured":"Jung JH, Ahn SV, Song JM, Chang SJ, Kim KJ, Kwon SW, et al. Obesity as a risk factor for prostatic enlargement: A retrospective cohort study in Korea. Int Neurourol J. 2016;20(4):321\u20138.","journal-title":"Int Neurourol J"},{"key":"266_CR27","doi-asserted-by":"crossref","unstructured":"Rehman IUR, Hussain SA, Khan H, Habib B, Sheikh R. The association between obesity and prostate volume in patients with benign prostatic hyperplasia. 2021;15(6):1888\u201391.","DOI":"10.53350\/pjmhs211561888"},{"issue":"3","key":"266_CR28","first-page":"198","volume":"20","author":"H Besiroglu","year":"2017","unstructured":"Besiroglu H, Dursun M, Otunctemur A, Ozbek E. The association between triglyceride high density lipoprotein cholesterol ratio and benign prostate hyperplasia in non-diabetic patients:a cross-sectional study. Aging Male. 2017;20(3):198\u2013204.","journal-title":"Aging Male"},{"issue":"1","key":"266_CR29","first-page":"317","volume":"11","author":"PG Cohen","year":"2012","unstructured":"Cohen PG. Abdominal obesity and intra-abdominal pressure: A new paradigm for the pathogenesis of the hypogonadal-obesity-BPH-LUTS connection. Horm Mol Biol Clin Investig. 2012;11(1):317\u201320.","journal-title":"Horm Mol Biol Clin Investig"},{"key":"266_CR30","doi-asserted-by":"publisher","unstructured":"Nandy PR, Saha S. Association between components of metabolic syndrome and prostatic enlargement: an Indian perspective. Med J Armed Forces India [Internet]. 2016;72(4):350\u20135. Available from: https:\/\/doi.org\/10.1016\/j.mjafi.2016.07.005.","DOI":"10.1016\/j.mjafi.2016.07.005"},{"issue":"1","key":"266_CR31","doi-asserted-by":"publisher","first-page":"9427","DOI":"10.1038\/s41598-019-45861-1","volume":"9","author":"ME Macpherson","year":"2019","unstructured":"Macpherson ME, Halvorsen B, Yndestad A, Ueland T, Mollnes TE, Berge RK, et al. Impaired HDL function amplifies systemic inflammation in common variable immunodeficiency. Sci Rep. 2019;9(1):9427.","journal-title":"Sci Rep"},{"issue":"1","key":"266_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12894-017-0211-9","volume":"17","author":"M Gacci","year":"2017","unstructured":"Gacci M, Sebastianelli A, Salvi M, De Nunzio C, Vignozzi L, Corona G, et al. Benign prostatic enlargement can be influenced by metabolic profile: results of a multicenter prospective study. BMC Urol. 2017;17(1):1\u20136.","journal-title":"BMC Urol"}],"container-title":["Cardiovascular Diabetology \u2013 Endocrinology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40842-025-00266-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40842-025-00266-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40842-025-00266-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T23:02:26Z","timestamp":1769986946000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40842-025-00266-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["266"],"URL":"https:\/\/doi.org\/10.1186\/s40842-025-00266-0","relation":{},"ISSN":["3059-4057"],"issn-type":[{"value":"3059-4057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was approved by an ethics review board of the Institute of Health, Jimma University with reference number JUIH\/IRB\/727\/23. A letter of permission was given to the JUMC chief clinical director, and finally, oral informed consent was taken from each study participant. Their right to refuse the study was fully respected. All research procedures were according to Helsinki declarations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}